Drug Type Small molecule drug |
Synonyms OKY-034, OKY034 |
Target |
Mechanism SLC7A5 inhibitors(L-type amino acid transporter 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Phase 2 | JP | 30 Jan 2022 | |
Pancreatic Cancer | Phase 2 | JP | 01 Mar 2019 | |
Brain Cancer | Preclinical | JP | 30 Jan 2022 | |
Multiple Sclerosis | Preclinical | JP | 30 Jan 2022 |